Nirvana Life Sciences (XCNQ:NIRV) Operating Cash Flow per Share : C$-0.01 (TTM As of Jan. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences Operating Cash Flow per Share?

Nirvana Life Sciences's operating cash flow per share for the three months ended in Jan. 2024 was C$0.00. Nirvana Life Sciences's operating cash flow per share for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -115.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -64.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Nirvana Life Sciences's Operating Cash Flow per Share or its related term are showing as below:

XCNQ:NIRV' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -135.1 Med: -115.4 Max: -35.7
Current: -115.4

During the past 6 years, Nirvana Life Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was -35.70% per year. The lowest was -135.10% per year. And the median was -115.40% per year.

XCNQ:NIRV's 3-Year OCF Growth Rate is ranked worse than
97.56% of 1232 companies
in the Biotechnology industry
Industry Median: 3.5 vs XCNQ:NIRV: -115.40

Nirvana Life Sciences Operating Cash Flow per Share Historical Data

The historical data trend for Nirvana Life Sciences's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences Operating Cash Flow per Share Chart

Nirvana Life Sciences Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Apr22

Apr23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.01

Nirvana Life Sciences Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Nirvana Life Sciences's Operating Cash Flow per Share

For the Biotechnology subindustry, Nirvana Life Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nirvana Life Sciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nirvana Life Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nirvana Life Sciences's Price-to-Operating-Cash-Flow falls into.

Nirvana Life Sciences Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Nirvana Life Sciences's Operating Cash Flow per Share for the fiscal year that ended in Apr. 2023 is calculated as

Operating Cash Flow per Share (A: Apr. 2023 )	=	Cash Flow from Operations (A: Apr. 2023 )	/	Shares Outstanding (Diluted Average) (A: Apr. 2023 )
	=	-0.333	/	33.944
	=	-0.01

Nirvana Life Sciences's Operating Cash Flow per Share for the quarter that ended in Apr. 2023 is calculated as

Operating Cash Flow per Share (Q: Jan. 2024 )	=	Cash Flow from Operations (Q: Jan. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Jan. 2024 )
	=	-0.008	/	48.233
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01

Nirvana Life Sciences Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Nirvana Life Sciences (XCNQ:NIRV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8

Website

https://www.nirvanalifescience.com

Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences (XCNQ:NIRV) Headlines

No Headlines